Emerging fluoroquinolone and ketolide resistance in Haemophilus parainfluenzae in South Africa

  • Regina Esinam Abotsi School of Health Science, University of Kwazulu Natal, Durban, South Africa
  • Usha Govinden School of Health Science, University of Kwazulu Natal, Durban, South Africa
  • Krishnee Moodley Lancet Laboratories, 102 Lancet Medical Centre, Durban, South Africa
  • Sabiha Yusuf Essack School of Health Science, University of Kwazulu Natal, Durban, South Africa

Abstract

This item has no abstract. Follow the links on the page to access the full text.

Author Biographies

Regina Esinam Abotsi, School of Health Science, University of Kwazulu Natal, Durban, South Africa

Bachelor of Pharmacy, MPSGh, MPharm(Pharmaceutical Microbiology)

Department of Pharmacy,

Antimicrobial Research Unit

Usha Govinden, School of Health Science, University of Kwazulu Natal, Durban, South Africa

PhD in Pharmaceutical Microbiology

Department of Pharmacy

Antimicrobial Research Unit

Krishnee Moodley, Lancet Laboratories, 102 Lancet Medical Centre, Durban, South Africa

Pathologist-Medical Microbiologist

Lancet Laboratories

Durban

Sabiha Yusuf Essack, School of Health Science, University of Kwazulu Natal, Durban, South Africa

B. Pharm., M. Pharm., PhD

South African Research Chair in Antibiotic Resistance & One Health

Professor:  Pharmaceutical Sciences

Director: Antimicrobial Research Unit

College of Health Sciences

University of KwaZulu-Natal

Private Bag X54001

Durban

4000

Published
2017-04-30
How to Cite
Abotsi R, Govinden U, Moodley K, Essack S (2017) Emerging fluoroquinolone and ketolide resistance in Haemophilus parainfluenzae in South Africa. The Journal Of Infection In Developing Countries 11 (04): 364-367. https://doi.org/10.3855/jidc.8241
Section
Letters to the Editor

Keywords

Haemophilus parainfluenzae; fluoroquinolone; telithromycin; antibiotic resistance; South Africa